ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Clinical trials for ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) explained in plain language.
Never miss a new study
Get alerted when new ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) trials appear
Sign up with your email to follow new studies for ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an allergy pill mend hearts after an attack?
Disease control Recruiting nowThis trial tests whether fexofenadine, a common allergy medication, can help the heart heal better after a severe type of heart attack called STEMI. Participants will receive either fexofenadine or a placebo for six months, alongside standard care, after undergoing a procedure to…
Matched conditions: ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Heart attack breakthrough: drugs may beat stents for mild blockages
Disease control Recruiting nowThis study looks at whether heart attack patients with mild artery narrowing can be treated with medication alone instead of getting a stent. About 2,000 people will be randomly assigned to either standard medication or medication plus a stent. The goal is to see if medication al…
Matched conditions: ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Phase: NA • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for heart attack patients: can a common blood thinner prevent strokes?
Disease control Recruiting nowThis study tests whether adding the blood thinner rivaroxaban (Xarelto) to standard care helps dissolve dangerous blood clots in the heart after a major heart attack. Researchers will track 320 participants to see if the drug reduces strokes and other complications. The goal is t…
Matched conditions: ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Phase: NA • Sponsor: Jilin University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Clot-Busting drug could change heart attack care
Disease control Recruiting nowThis study compares two drugs given directly into the heart arteries during a heart attack: rhTNK-tPA, a clot dissolver, and tirofiban, a blood thinner. Researchers will enroll 300 patients with severe blockages to see which drug restores blood flow better and causes fewer bleedi…
Matched conditions: ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Phase: PHASE4 • Sponsor: Henan Institute of Cardiovascular Epidemiology • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a cheap heart drug prevent 'No-Reflow' during heart attack treatment?
Disease control Recruiting nowThis study tests whether giving the drug adenosine just before emergency angioplasty (PCI) can improve blood flow in heart attack patients. About 1,148 adults having a severe type of heart attack (STEMI) will either receive adenosine or standard care. The goal is to see if adenos…
Matched conditions: ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Phase: PHASE4 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Massive study tracks 1,000 heart attack survivors to unlock recovery secrets
Knowledge-focused Recruiting nowThis study is following 1,000 people who have had a severe type of heart attack called STEMI. Researchers are collecting detailed medical data to understand how different organs talk to each other during recovery. The goal is to find key signals that could lead to better treatmen…
Matched conditions: ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI)
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC